Ken Griffin’s CorMedix CRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.88M | Buy |
276,300
+178,100
| +181% | +$1.32M | ﹤0.01% | 6198 |
|
|
2025
Q4 | $1.14M | Sell |
98,200
-18,900
| -16% | -$209K | ﹤0.01% | 7097 |
|
|
2025
Q3 | $1.36M | Sell |
117,100
-10,000
| -8% | -$121K | ﹤0.01% | 6863 |
|
|
2025
Q2 | $1.57M | Sell |
127,100
-39,700
| -24% | -$438K | ﹤0.01% | 6176 |
|
|
2025
Q1 | $1.03M | Buy |
166,800
+32,300
| +24% | +$334K | ﹤0.01% | 6894 |
|
|
2024
Q4 | $1.09M | Buy |
134,500
+115,600
| +612% | +$1.15M | ﹤0.01% | 6830 |
|
|
2024
Q3 | $153K | Buy |
18,900
+1,900
| +11% | +$10.3K | ﹤0.01% | 10543 |
|
|
2024
Q2 | $73.6K | Sell |
17,000
-13,200
| -44% | -$67.1K | ﹤0.01% | 11313 |
|
|
2024
Q1 | $128K | Buy |
30,200
+22,300
| +282% | +$77.3K | ﹤0.01% | 11012 |
|
|
2023
Q4 | $29.7K | Sell |
7,900
-23,800
| -75% | -$81.9K | ﹤0.01% | 12275 |
|
|
2023
Q3 | $117K | Sell |
31,700
-11,800
| -27% | -$46.9K | ﹤0.01% | 10694 |
|
|
2023
Q2 | $172K | Sell |
43,500
-1,400
| -3% | -$6.93K | ﹤0.01% | 10113 |
|
|
2023
Q1 | $186K | Buy |
44,900
+32,700
| +268% | +$134K | ﹤0.01% | 10305 |
|
|
2022
Q4 | $51.5K | Sell |
12,200
-17,000
| -58% | -$60.1K | ﹤0.01% | 12098 |
|
|
2022
Q3 | $83K | Buy |
29,200
+2,300
| +9% | +$9.57K | ﹤0.01% | 11244 |
|
|
2022
Q2 | $108K | Buy |
26,900
+4,300
| +19% | +$16K | ﹤0.01% | 11334 |
|
|
2022
Q1 | $124K | Buy |
22,600
+200
| +0.9% | +$916 | ﹤0.01% | 12058 |
|
|
2021
Q4 | $102K | Sell |
22,400
-15,900
| -42% | -$78.9K | ﹤0.01% | 12702 |
|
|
2021
Q3 | $178K | Sell |
38,300
-44,300
| -54% | -$258K | ﹤0.01% | 12145 |
|
|
2021
Q2 | $567K | Sell |
82,600
-10,500
| -11% | -$83.5K | ﹤0.01% | 9780 |
|
|
2021
Q1 | $930K | Buy |
93,100
+53,900
| +138% | +$567K | ﹤0.01% | 8301 |
|
|
2020
Q4 | $291K | Sell |
39,200
-3,500
| -8% | -$23.8K | ﹤0.01% | 9130 |
|
|
2020
Q3 | $257K | Buy |
42,700
+14,000
| +49% | +$70.3K | ﹤0.01% | 8395 |
|
|
2020
Q2 | $181K | Buy |
28,700
+15,500
| +117% | +$71.8K | ﹤0.01% | 8603 |
|
|
2020
Q1 | $47K | Buy |
+13,200
| New | +$74.6K | ﹤0.01% | 9055 |
|
|
2019
Q3 | – | Sell |
-25,800
| Closed | -$231K | – | 9226 |
|
|
2019
Q2 | $231K | Buy |
25,800
+15,700
| +155% | +$123K | ﹤0.01% | 7984 |
|
|
2019
Q1 | $95K | Buy |
10,100
+3,320
| +49% | +$29.9K | ﹤0.01% | 8577 |
|
|
2018
Q4 | $44K | Buy |
+6,780
| New | +$45.3K | ﹤0.01% | 8521 |
|
|
2017
Q1 | – | Sell |
-2,120
| Closed | -$16K | – | 7502 |
|
|
2016
Q4 | $16K | Buy |
+2,120
| New | +$21.4K | ﹤0.01% | 7120 |
|
|
2016
Q1 | – | Sell |
-340
| Closed | -$3K | – | 6938 |
|
|
2015
Q4 | $3K | Sell |
340
-860
| -72% | -$9.9K | ﹤0.01% | 8525 |
|
|
2015
Q3 | $12K | Sell |
1,200
-360
| -23% | -$5.55K | ﹤0.01% | 8399 |
|
|
2015
Q2 | $30K | Buy |
1,560
+600
| +63% | +$20.6K | ﹤0.01% | 7959 |
|
|
2015
Q1 | $47K | Buy |
+960
| New | +$22.8K | ﹤0.01% | 7416 |
|
Other funds holding CRMD
DTC
VCM
RA
OAM
VPM
Ken Griffin's CRMD Position: Q1 2026 in Review
Ken Griffin reduced its CorMedix (CRMD) stake by 24% in Q1 2026, selling an estimated $573K and leaving 242,612 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #6520.
Ken Griffin first reported a position in CRMD in Q1 2015 and has held it in 38 quarters since. The position peaked at $21.1M in Q2 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.
- Ken Griffin held 242,612 shares of CorMedix worth $1.65M as of Q1 2026.
- Ken Griffin sold 77,538 CorMedix shares in Q1 2026, an estimated $573K.
- CorMedix made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #6520 holding.
- Ken Griffin first reported a position in CorMedix in Q1 2015 and has held it in 38 quarters since.
- Ken Griffin's CorMedix position peaked at $21.1M in Q2 2025.
- 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.